pyrazole has been researched along with Liver Neoplasms in 7 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dömötör, O | 1 |
| Kiss, MA | 1 |
| Gál, GT | 1 |
| May, NV | 1 |
| Spengler, G | 1 |
| Nové, M | 1 |
| Gašparović, AČ | 1 |
| Frank, É | 1 |
| Enyedy, ÉA | 1 |
| Shen, M | 1 |
| Xu, M | 1 |
| Zhong, F | 1 |
| Crist, MC | 1 |
| Prior, AB | 1 |
| Yang, K | 1 |
| Allaire, DM | 1 |
| Choueiry, F | 1 |
| Zhu, J | 1 |
| Shi, H | 1 |
| Elshaier, YAMM | 1 |
| Shaaban, MA | 1 |
| Abd El Hamid, MK | 1 |
| Abdelrahman, MH | 1 |
| Abou-Salim, MA | 1 |
| Elgazwi, SM | 1 |
| Halaweish, F | 1 |
| Harras, MF | 1 |
| Sabour, R | 1 |
| Zhang, H | 1 |
| Zhu, P | 1 |
| Liu, J | 1 |
| Lin, Y | 1 |
| Yao, H | 1 |
| Jiang, J | 1 |
| Ye, W | 1 |
| Wu, X | 1 |
| Xu, J | 1 |
| Hawash, MM | 1 |
| Kahraman, DC | 1 |
| Eren, F | 1 |
| Cetin Atalay, R | 1 |
| Baytas, SN | 1 |
| Nieto, N | 1 |
| Marí, M | 1 |
| Cederbaum, AI | 1 |
7 other studies available for pyrazole and Liver Neoplasms
| Article | Year |
|---|---|
Solution equilibrium, structural and cytotoxicity studies on Ru(η
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; C | 2020 |
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Topics: Cell Count; Cell Proliferation; Deoxyglucose; Estradiol; Estrogens; Gene Expression Regulation, Neop | 2021 |
Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Design; Hep G | 2017 |
Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; CDC2 Protein Kinase; Cell Cy | 2018 |
Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, | 2015 |
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Prot | 2017 |
Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit.
Topics: 5' Flanking Region; Allyl Compounds; Animals; Antioxidants; Arachidonic Acid; Carcinoma, Hepatocellu | 2003 |